IL69381A - Azetidine compounds and pharmaceutical compositions containing the same - Google Patents

Azetidine compounds and pharmaceutical compositions containing the same

Info

Publication number
IL69381A
IL69381A IL69381A IL6938183A IL69381A IL 69381 A IL69381 A IL 69381A IL 69381 A IL69381 A IL 69381A IL 6938183 A IL6938183 A IL 6938183A IL 69381 A IL69381 A IL 69381A
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
azetidine compounds
azetidine
Prior art date
Application number
IL69381A
Other languages
English (en)
Other versions
IL69381A0 (en
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IL69381A0 publication Critical patent/IL69381A0/xx
Publication of IL69381A publication Critical patent/IL69381A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL69381A 1982-08-04 1983-08-01 Azetidine compounds and pharmaceutical compositions containing the same IL69381A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40494582A 1982-08-04 1982-08-04

Publications (2)

Publication Number Publication Date
IL69381A0 IL69381A0 (en) 1983-11-30
IL69381A true IL69381A (en) 1987-07-31

Family

ID=23601669

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69381A IL69381A (en) 1982-08-04 1983-08-01 Azetidine compounds and pharmaceutical compositions containing the same

Country Status (33)

Country Link
US (1) US4939253A (ro)
JP (1) JPS5993046A (ro)
KR (1) KR900001211B1 (ro)
AR (1) AR241158A1 (ro)
AT (1) AT382367B (ro)
AU (1) AU568086B2 (ro)
BE (1) BE897466A (ro)
CH (1) CH655309A5 (ro)
CS (4) CS26783A2 (ro)
DD (1) DD213919A5 (ro)
DE (1) DE3328047A1 (ro)
DK (1) DK354683A (ro)
ES (1) ES8502114A1 (ro)
FI (1) FI832675A (ro)
FR (1) FR2531427A1 (ro)
GB (1) GB2125794B (ro)
GR (1) GR79368B (ro)
HU (1) HU191058B (ro)
IE (1) IE55839B1 (ro)
IL (1) IL69381A (ro)
IN (1) IN160955B (ro)
IT (1) IT1224129B (ro)
LU (1) LU84947A1 (ro)
NL (1) NL8302746A (ro)
NO (1) NO832801L (ro)
NZ (1) NZ205111A (ro)
PL (3) PL257440A1 (ro)
PT (1) PT77155B (ro)
RO (1) RO86511B (ro)
SE (1) SE8304256L (ro)
SU (1) SU1329617A3 (ro)
YU (1) YU43324B (ro)
ZA (1) ZA835470B (ro)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs
US4548747A (en) * 1983-05-02 1985-10-22 E. R. Squibb & Sons, Inc. 3-Acylamino-1-sulfonylaminocarbonylmethoxy-2-azetidinones
ATE39356T1 (de) * 1983-05-31 1989-01-15 Squibb & Sons Inc (((3-acylamino-2-oxo-1-azetidinyl)oxy>methyl>phosphins|ure.
US4534896A (en) * 1983-06-13 1985-08-13 E. R. Squibb & Sons, Inc. 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
US4548751A (en) * 1983-08-03 1985-10-22 E. R. Squibb & Sons, Inc. (2-Oxo-1-azetidinyloxy)-2-propenoic acid
AU581180B2 (en) * 1983-08-26 1989-02-16 E.R. Squibb & Sons, Inc. 1-(1h-tetrazol-5-ylalkoxy)-2-azetidinones
CA1243679A (en) * 1983-09-14 1988-10-25 Henner Straub 3-ACYLAMINO-2-OXO-1-AZETIDINYL-.beta.-OXYPROPIONATES
EP0135194A1 (en) * 1983-09-16 1985-03-27 Takeda Chemical Industries, Ltd. Azetidinones and their production
WO1985004876A1 (en) * 1984-04-24 1985-11-07 Takeda Chemical Industries, Ltd. 2-azetidinone derivatives and process for their preparation
US4559335A (en) * 1983-10-03 1985-12-17 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethyloxy (or thio) carbonyl-2-azetidinones
US4576749A (en) * 1983-10-03 1986-03-18 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
US4551277A (en) * 1983-11-09 1985-11-05 E. R. Squibb & Sons, Inc. 4-(3-Acylamino-2-oxo-1-azetidinyl)-4-oxo-2-butenoic acid
US4581170A (en) * 1984-08-03 1986-04-08 E. R. Squibb & Sons, Inc. N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
US5112968A (en) * 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
US20080161249A1 (en) * 2004-11-17 2008-07-03 Smithkline Beecham Corporation Use of Novel Antibacterial Compounds
CN103724330B (zh) * 2005-12-07 2015-08-19 巴斯利尔药物股份公司 单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用
WO2014164526A1 (en) * 2013-03-13 2014-10-09 Rempex Pharmaceuticals, Inc. Oxamazin antibiotics
US20140275007A1 (en) * 2013-03-14 2014-09-18 Rempex Pharmaceuticals, Inc. Oxamazin antibiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ205240A (en) * 1980-02-07 1984-07-31 Squibb & Sons Inc Sulphonamide derivatives,being starting materials for producing beta-lactams
EP0048953B1 (en) * 1980-09-29 1988-03-09 E.R. Squibb & Sons, Inc. Beta-lactam antibiotics
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
WO1982001873A1 (en) * 1980-12-05 1982-06-10 Takeda Chemical Industries Ltd 1-sulfo-2-oxoazetidine derivatives and process for their preparation
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs

Also Published As

Publication number Publication date
PT77155B (en) 1986-01-28
AR241158A1 (es) 1991-12-30
JPS5993046A (ja) 1984-05-29
IN160955B (ro) 1987-08-22
GB2125794A (en) 1984-03-14
RO86511A (ro) 1985-03-15
FR2531427A1 (fr) 1984-02-10
SE8304256L (sv) 1984-02-05
ES524698A0 (es) 1984-12-16
KR900001211B1 (ko) 1990-02-28
IE831830L (en) 1984-02-04
IL69381A0 (en) 1983-11-30
CS243499B2 (en) 1986-06-12
AU1755683A (en) 1984-02-09
ZA835470B (en) 1984-04-25
HU191058B (en) 1986-12-28
ES8502114A1 (es) 1984-12-16
FR2531427B1 (ro) 1985-04-19
BE897466A (fr) 1984-02-06
ATA281283A (de) 1986-07-15
CH655309A5 (fr) 1986-04-15
PL257441A1 (en) 1986-10-07
NL8302746A (nl) 1984-03-01
NZ205111A (en) 1986-06-11
SU1329617A3 (ru) 1987-08-07
CS575983A2 (en) 1985-08-15
FI832675A0 (fi) 1983-07-22
SE8304256D0 (sv) 1983-08-03
YU162783A (en) 1986-02-28
DK354683A (da) 1984-02-05
US4939253A (en) 1990-07-03
LU84947A1 (fr) 1984-03-23
PL257440A1 (en) 1986-10-07
CS243474B2 (en) 1986-06-12
RO86511B (ro) 1985-03-31
CS243498B2 (en) 1986-06-12
IT1224129B (it) 1990-09-26
FI832675A (fi) 1984-02-05
GB2125794B (en) 1985-12-18
GB8320497D0 (en) 1983-09-01
AR241158A2 (es) 1991-12-30
CS26885A2 (en) 1985-08-31
PL243308A1 (en) 1985-12-17
DD213919A5 (de) 1984-09-26
DE3328047A1 (de) 1984-02-09
DK354683D0 (da) 1983-08-03
PT77155A (en) 1983-09-01
NO832801L (no) 1984-02-06
CS26783A2 (en) 1985-08-31
AU568086B2 (en) 1987-12-17
GR79368B (ro) 1984-10-22
IE55839B1 (en) 1991-01-30
KR840005814A (ko) 1984-11-19
AT382367B (de) 1987-02-25
IT8322430A0 (it) 1983-08-04
CS26785A2 (en) 1985-08-15
YU43324B (en) 1989-06-30

Similar Documents

Publication Publication Date Title
GB8326565D0 (en) Pharmaceutical compositions
GB8327612D0 (en) Pharmaceutical compositions
ZA834074B (en) Pharmaceutical composition
IL69381A (en) Azetidine compounds and pharmaceutical compositions containing the same
ZA833781B (en) Pharmaceutical compositions
EP0093551A3 (en) Pharmaceutical composition
GB2118176B (en) Pharmaceutical compositions
PT79152B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
PT77323A (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
GB8329700D0 (en) Anti-haemophilic pharmaceutical composition
DE3377696D1 (en) Pharmaceutical compositions
GB8328896D0 (en) Pharmaceutical composition
IL70379A (en) Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them
US4594359B1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
IL68668A0 (en) Piperidinoquinazolines and pharmaceutical compositions containing them
GB8305028D0 (en) Pharmaceutical compositions
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
GB8332653D0 (en) Pharmaceutical composition
GB8314736D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8331068D0 (en) Pharmaceutical compositions